Cuprina Holdings (Cayman) Ltd (CUPR) - Forward P/S Multiple

Corporate company logo of Cuprina Holdings Limited (CUPR)

Cuprina Holdings (Cayman) Ltd (CUPR) is implementing innovative wound-healing solutions in Asian clinics, ensuring stable sales. The GURU.Markets portal features a chart of the forward P/S trend, where the 320.90 mark indicates the current state. Despite pressure from tech behemoths, sustained demand for biotechnology shields the company from market volatility, maintaining its growth trajectory.

CUPR cuprina.com.sg: Market Cap to Projected Revenue in the range 05/17/2025 - 11/18/2026

Comprehensive metric breakdowns and analytics for Cuprina Holdings (Cayman) Ltd (CUPR)

- market price and analyst price targets:
Summary company analysis:CUPR (cuprina.com.sg)
Manufactured products of Cuprina Holdings Limited

For Cuprina Holdings (Cayman) Ltd (CUPR), which implements unique larval therapy for the treatment of chronic wounds, revenue dynamics serve as the key driver of capitalization. The forward P/S multiple compares the company's current market value with expected sales volume, updating the valuation daily to eliminate information gaps between quarterly reports. The rise of this curve reflects market optimism regarding the commercialization of innovations, yet signals the risk of overpaying for the asset.

Competitor analysis

Forward P/S Multiple HCA (HCA Healthcare, Inc.)|Price to Expected Revenue Ratio THC (Tenet Healthcare)|FMS - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio solventum.com|EHC: Forward P/S Multiple|UHS - Market Cap to Expected Sales Ratio|DVA (DaVita Corp) - Forward P/S Multiple|RDNT: Forward Price to Sales|Forward P/S Multiple OPCH|SGRY (surgerypartners.com) - Forward Price to Sales|Forward P/S Multiple PINC (Premier Inc)|National Vision - Price-to-Projected Revenue Ratio|PGNY - Price-to-Projected Revenue Ratio|ARDT - Forward P/S Multiple|SEM: Forward P/S Multiple|astranahealth.com (ASTH) - Forward P/S Multiple|MD (mednax.com) - Forward P/S Multiple|Forward P/S Multiple usph.com|Forward P/S Multiple PNTG|Market Cap to Expected Sales Ratio Organogenesis Holdings|Forward P/S Multiple NUTX (nutexhealth.com)|Auna SA (AUNA) - Market Cap to Future Revenue Ratio|SBC: Forward Price-to-Revenue Multiple|Market Cap to Expected Sales Ratio Jeuveau EOLS|CYH (Community Health Systems Inc) - Forward Price-to-Revenue Multiple|SKIN: Price to Expected Revenue Ratio|Forward Price-to-Revenue Multiple MDWD|BTMD: Forward Price to Sales|Price-to-Projected Revenue Ratio The Joint Corporation (JYNT)|Forward P/S Multiple DocGo Inc (DCGO)|Forward Price to Sales P3 Health Partners, Inc.|Market Cap to Expected Sales Ratio gaintherapeutics.com (GANX)|EUDA: Forward Price-to-Revenue Multiple|BMGL: Price-to-Projected Revenue Ratio|collplant.com (CLGN) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple Concord Medical|AMS (American Shared Hospital Services Inc) - Forward P/S Multiple|MEDIROM Corp (MRM) - Market Cap to Expected Sales Ratio|Forward P/S Multiple ALBT|Market Cap to Expected Sales Ratio DIH Holding|Forward P/S Multiple XAGE (carmellcosmetics.com)|NIVF: Market Cap to Projected Revenue|ATIP: Forward Price-to-Revenue Multiple|CareMax Medical Group - Price to Expected Revenue Ratio|Kindly MD (KDLY) - Price-to-Projected Revenue Ratio|Market Cap to Projected Revenue MODV|Price-to-Projected Revenue Ratio Novo Integrated Sciences Corp|Market Cap to Future Revenue Ratio SunLink Health Systems SSY|Price-to-Projected Revenue Ratio IMAC Corp (BACK)